Opko Health (OPK) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.05
- Estimate
- -$0.06
- Surprise
- +21.1%
- Revenue (period 2026-09-30)
- $65.4M
- Score today
- 5.2/10
Revenue source: xbrl.
How the report landed
Opko Health (OPK) reported adjusted EPS of -$0.05, in line with the -$0.06 estimate.
Coverage in the report window
- CORRECTION: OPKO Health Q3 EPS $(0.05) Beats $(0.06) Estimate, Sales $65.400M Miss $141.267M Estimate — benzinga, 2026-11-04
- OPKO Health FY2026 Sales from continuing operations of Guidance of $268.000M-$278.000M — benzinga, 2026-11-04
- OPKO Health Sees Q4 Sales $62.000M-$72.000M — benzinga, 2026-11-04
Where TrendMatrix's rating stands now
TrendMatrix currently rates OPK Sell at 5.2/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's +21.1% surprise compares with a +35.0% four-quarter average. Next scheduled report: 2027-03-01.
What argues against it
- Concentration risk — Geographic: New York and New Jersey
- Concentration risk — Counterparty: Pfizer
- Quality below floor (2.2 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $1.84
- Price target
- $3.61
- Stop
- $1.71
- Upside to target
- +96.2%
- Reward-to-risk
- 6.4:1
Risk check: RSI 77 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
OPK at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Diagnostics & Research
- Market cap
- $1.31B
- P/E (fwd)
- -5.1
- 52-week range
- $0.98–$1.83
- Off 52-week high
- -0.5%
- RSI (14)
- 77
- Volume vs avg
- 0.32×
- Score today
- 5.2/10